US Fertility Chooses Alife Health's Embryo Image Capture and Reporting Platform to Engage IVF Patients and Increase Clinical Efficiency Nationwide
US Fertility Chooses Alife Health's Embryo Image Capture and Reporting Platform to Engage IVF Patients and Increase Clinical Efficiency Nationwide
SAN FRANCISCO and LOS ANGELES, March 17, 2025 /PRNewswire/ -- Alife Health (Alife), a leading provider of AI-powered tools to advance the in-vitro fertilization (IVF) process, is excited to expand its partnership with US Fertility, the nation's largest partnership of physician-owned fertility practices. In a move set to reshape the industry, US Fertility and Alife will provide each patient with her personalized, AI-driven IVF laboratory summary report, including embryo images, laboratory-generated grading, clinical significance, and next steps. This is a landmark in the integration of AI technology into reproductive healthcare. Further, it solidifies US Fertility's leadership in innovation and Alife's position as the go-to provider of AI-powered solutions for IVF.
舊金山和洛杉磯,2025年3月17日 /PRNewswire/ -- Alife Health (Alife),一家領先的人工智能驅動的工具提供商,旨在提升體外受精(IVF)過程的效率,興奮地擴展與 美國生育,美國最大的醫生擁有生育診所合作伙伴。爲了重塑行業,美國生育和Alife將爲每位患者提供個性化的人工智能驅動IVF實驗室總結報告,其中包括胚胎圖像、實驗室生成的評分、臨牀意義和後續步驟。這是人工智能技術與生殖醫療整合的一個里程碑。此外,這鞏固了美國生育在創新方面的領導地位,同時也鞏固了Alife作爲IVF人工智能驅動解決方案首選提供商的地位。
With more than 100 clinics and 32 IVF laboratories across the United States, US Fertility serves tens of thousands of patients annually on their journeys to build families. The nationwide adoption of Alife technology represents US Fertility's continued commitment to enhancing the precision, efficiency, and consistency of their IVF processes, with the goal of providing optimal and individualized care to every patient.
美國生育在美國設有超過100家診所和32個IVF實驗室,每年服務數萬名患者,幫助他們建立家庭。Alife技術在全國的普及代表了美國生育對提升IVF過程的精確性、效率和一致性的持續承諾,旨在爲每位患者提供最佳和個性化的護理。
"Partnering with Alife is a transformative step forward for US Fertility," says Richard Jennings, CEO of US Fertility.
「與Alife的合作是美國生育向前邁出的變革性一步,」美國生育首席執行官理查德·詹寧斯說。
"Partnering with Alife is a transformative step forward for US Fertility," says Richard Jennings, Chief Executive Officer of US Fertility. "Alife's embryo imaging technology furnishes reports sent directly to patients. This facilitates patient engagement with the IVF lab. By embracing AI, US Fertility is setting a new industry standard in how IVF is delivered, streamlining clinical workflow and optimizing patient experience across our nationwide network."
"與Alife的合作是美國生育行業向前邁出的重要一步,"美國生育的首席執行官理查德·詹寧斯表示。"Alife的胚胎成像技術提供直接發送給患者的報告。這促進了患者與IVF實驗室的互動。通過採用人工智能,美國生育正在爲IVF的交付設定新的行業標準,簡化臨牀流程並優化我們全國網絡中的患者體驗。"
Alife's Embryo Assist tool is designed to streamline and digitize the traditionally manual process of embryo grading. With seamless microscope integration and real-time connection to electronic medical records (EMR), the software allows embryologists to capture, rank, and organize embryo data in one place, reducing the time spent on manual documentation. The tool not only saves valuable time—up to 15 minutes per cycle per embryologist—but also provides real-time lab updates, ensuring embryologists have immediate access to the latest data for faster and more informed decision-making. Additionally, the software generates personalized embryo reports for patients, helping them better understand their IVF journey with clear, data-driven insights. This combination of operational efficiency and patient-centric reporting elevates the overall IVF experience.
Alife的胚胎助手工具旨在簡化和數字化傳統手動的胚胎評分過程。通過無縫顯微鏡集成和與電子病歷(EMR)的實時連接,該軟體允許胚胎學家在一個地方捕捉、排名和組織胚胎數據,減少手動文檔記錄的時間。這個工具不僅節省了寶貴的時間——每個胚胎學家每個週期最多可節省15分鐘——還提供實時實驗室更新,確保胚胎學家能夠立即訪問最新數據,以便更快和更明智的決策。此外,該軟體爲患者生成個性化的胚胎報告,幫助他們更好地理解他們的IVF旅程,提供清晰的數據驅動洞察。這種運營效率和以患者爲中心的報告的結合提升了整體IVF體驗。
Kate Devine, MD, Medical Director and Chief Research Officer of US Fertility, added: "Integrating AI via Alife's state-of-the-art, direct-to-patient embryo vitrification reporting marks an exciting evolution for US Fertility. We've seen first-hand how it boosts operational efficiencies and elevates patient experience."
"US Fertility的醫療主任兼首席研究官凱特·德維恩博士補充說:"通過Alife先進的直接面向患者的胚胎冷凍報告整合人工智能標誌着美國生育的激動人心的進展。我們親眼見證了它如何提升運營效率和改善患者體驗。"
"This partnership with US Fertility is a true gamechanger for the fertility industry," says Melissa Teran, Chief Executive Officer of Alife. "As the largest player in the field, their adoption of our tool is a huge vote of confidence in Alife's technological approach to IVF. We are honored to help optimize their embryology reporting and provide their teams with the tools they need to improve patient care. This collaboration demonstrates how AI is poised to play a pivotal role in the future of fertility treatments."
"與美國生育的合作是生育行業的真正遊戲規則改變者,"Alife的首席執行官梅利莎·特倫表示。"作爲該領域最大的參與者,他們對我們工具的採用是在對Alife在IVF中的技術方法的巨大信任。我們很榮幸能夠幫助優化他們的胚胎報告,併爲他們的團隊提供改善患者護理所需的工具。這個合作展示了人工智能將在未來的生育治療中發揮重要作用。"
The nationwide rollout of Alife technology by US Fertility marks a new era of efficiency, precision, and data-driven decision-making for fertility labs, ultimately advancing the way IVF is performed on a large scale.
美國生育公司全面推廣Alife科技,標誌着生育實驗室在效率、精確性和數據驅動決策方面的新紀元,最終推動了大規模試管嬰兒(IVF)的實施方式。
About Alife Health
Alife Health is modernizing and personalizing the IVF process with cutting-edge AI technology designed to improve clinical outcomes and patient care. With partnerships across the top clinics and renowned physicians in the field, Alife is transforming reproductive healthcare. Recognized by Fast Company as one of the Most Innovative Companies of 2024, Alife is pioneering AI solutions that support embryologists, clinics, and patients on the IVF journey: .
關於Alife Health
Alife健康正在通過尖端人工智能科技現代化和個性化試管嬰兒(IVF)過程,旨在改善臨牀結果和患者護理。與頂級診所和知名醫生的合作,Alife正在改變生殖醫療保健。被Fast Company評選爲2024年最具創新公司的Alife正在開創支持胚胎學家、診所和患者在試管嬰兒旅程中所需的人工智能解決方案:.
About US Fertility
US Fertility, the nation's largest partnership of physician-owned fertility practices, along with Ovation Fertility, a national network of premier IVF laboratories, are united under a shared mission to deliver the joy of parenthood through advanced reproductive medicine and innovative science. To date, US Fertility and Ovation Fertility practices have helped more than 225,000 individuals and couples build their families using assisted reproductive technology. US Fertility supports over 200 physicians by leveraging collective expertise, driving innovation, and providing advanced business and digital solutions that streamline and enhance the delivery of exceptional patient care. Together with a growing suite of life science services, US Fertility is expanding access to the highest quality reproductive health care across over 100 clinic locations and 32 IVF laboratories:
關於美國生育公司
美國生育作爲全國最大的醫生擁有生育醫療機構合作體,以及Ovation Fertility這一全國頂級試管嬰兒實驗室網絡,共同以一個使命團結在一起,通過先進的生殖醫學和創新科學傳遞爲人父母的快樂。迄今爲止,美國生育公司和Ovation Fertility的診所已經幫助超過225,000名個人和夫婦使用輔助生殖技術建立他們的家庭。美國生育公司通過利用集體專業知識、推動創新並提供先進的業務和數字解決方案,支持超過200名醫生,從而簡化和提升卓越患者護理的交付。與日益增長的生命科學服務套件一起,美國生育公司正在擴展在超過100個診所位置和32個試管嬰兒實驗室中提供高質量生殖醫療保健的機會:
Contact Info
聯繫信息
Alife Health: Jamie Gray, [email protected]
US Fertility: Chad Tulloch, [email protected]
Alife Health: 傑米·格雷, [email protected]
美國生育率:查德·圖洛赫, [email protected]
SOURCE Alife Health
來源 Alife Health
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您的公司的資訊出現在PRNEWSWIRE.COM上嗎?
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因